Impax Asset Management Group
ABBV icon

Impax Asset Management Group’s AbbVie ABBV Stock Holding History

Impax Asset Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.9M Buy
43,138
+15,738
+57% +$3.39M 0.07% 165
2026
Q1 		$5.96M Buy
27,400
+22,068
+414% +$4.9M 0.04% 198
2025
Q4 		$1.22M Hold
5,332
– – 0.01% 257
2025
Q3 		$1.23M Hold
5,332
– – 0.01% 246
2025
Q2 		$990K Buy
+5,332
New +$991K 0.01% 275
2024
Q3 		– Sell
-3,800
Closed -$652K – 314
2024
Q2 		$652K Sell
3,800
-29,364
-89% -$4.86M ﹤0.01% 299
2024
Q1 		$6.04M Sell
33,164
-3,310
-9% -$570K 0.02% 205
2023
Q4 		$5.65M Sell
36,474
-18,465
-34% -$2.69M 0.02% 207
2023
Q3 		$8.19M Sell
54,939
-9,506
-15% -$1.4M 0.04% 176
2023
Q2 		$8.68M Buy
64,445
+1,368
+2% +$201K 0.03% 171
2023
Q1 		$10.1M Sell
63,077
-608
-1% -$93K 0.04% 157
2022
Q4 		$10.3M Sell
63,685
-7,935
-11% -$1.22M 0.05% 155
2022
Q3 		$9.61M Sell
71,620
-3,964
-5% -$569K 0.05% 152
2022
Q2 		$11.6M Sell
75,584
-4,041
-5% -$617K 0.06% 143
2022
Q1 		$12.9M Buy
79,625
+2,984
+4% +$433K 0.05% 143
2021
Q4 		$10.4M Sell
76,641
-3,273
-4% -$387K 0.04% 160
2021
Q3 		$8.62M Buy
79,914
+201
+0.3% +$23K 0.04% 170
2021
Q2 		$8.98M Buy
79,713
+5
+0% +$563 0.04% 167
2021
Q1 		$8.63M Buy
79,708
+26,201
+49% +$2.8M 0.04% 152
2020
Q4 		$5.73M Buy
+53,507
New +$5.14M 0.04% 159

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Impax Asset Management Group's ABBV Position: Q2 2026 in Review

Impax Asset Management Group increased its AbbVie (ABBV) stake by 57% in Q2 2026, buying an estimated $3.39M and bringing the position to 43,138 shares worth $10.9M. The position accounts for 0.07% of the portfolio, ranked #165.

Impax Asset Management Group first reported a position in ABBV in Q4 2020 and has held it in 20 quarters since. The position peaked at $12.9M in Q1 2022. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Impax Asset Management Group held 43,138 shares of AbbVie worth $10.9M as of Q2 2026.
  • Impax Asset Management Group bought 15,738 AbbVie shares in Q2 2026, an estimated $3.39M.
  • AbbVie made up 0.07% of Impax Asset Management Group's portfolio in Q2 2026, its #165 holding.
  • Impax Asset Management Group first reported a position in AbbVie in Q4 2020 and has held it in 20 quarters since.
  • Impax Asset Management Group's AbbVie position peaked at $12.9M in Q1 2022.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Impax Asset Management Group's 13F filing for Q2 2026, filed 11 Aug 2026.